COVID-19: Vaccines and Therapeutics

This week, drug maker AstraZeneca requested an emergency use authorization (EUA) from the Food and Drug Administration for its long-acting antibody
The Food and Drug Administration this week amended Pfizer’s emergency use authorization for its COVID-19 vaccine
Last week, the Biden-Harris Administration announced $2.1 billion in American Rescue Plan funding will be used to improve infection prevention and control activities across
This summer, when the delta variant of the coronavirus became predominant, the risk of infection among fully vaccinated people was reduced 5-fold, and the risk of
President Biden this week announced six new mitigation steps for combatting the COVID-19 pandemic, including a series of vaccine mandates for certain workers nationwide.
The United States will spend $1.7 billion to track variants of the SARS-CoV-2 virus. These variants, which are more transmissible than the coronavirus that originally infected North
The American Nurses Association joined AONL and other nursing and health care organizations to launch COVID Vaccine Facts for Nurses, a vaccine education campaign.
Findings from an Israeli study provide “preliminary but important evidence of the effectiveness of vaccines in preventing severe cases of COVID-19 at the national level
The influenza vaccine appears to provide some protection against COVID-19, according to a retrospective cohort study using data from 4.5 million patients
Increasing the number of vaccines delivered will require more predictable vaccine shipments, overcoming vaccine hesitancy, and public and private partnerships, said AONL CEO Robyn Begley, DNP, RN, who is also chief nursing officer and senior vice president workforce for the American Hospital…